Chemerin alleviates the placental oxidative stress and improves fetal overgrowth of gestational diabetes mellitus mice induced by high fat diet

Evidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the progression of this condition. Adipokine chemerin was linked with GDM, yet the roles of chemerin in placental oxidative stress and its underlyi...

Full description

Saved in:
Bibliographic Details
Published inMolecular medicine (Cambridge, Mass.) Vol. 30; no. 1; pp. 239 - 16
Main Authors Zhou, Xuan, Jiang, Yi, Wang, Zizhuo, Wei, Lijie, Zhang, Huiting, Fang, Chenyun, Zhu, Shenglan, Du, Yuanyuan, Su, Rui, Li, Weikun, He, Zhenzhen, Zhang, Liangnan, Tan, Weidong, He, Mengzhou, Yu, Jun, Wang, Shaoshuai, Ding, Wencheng, Feng, Ling
Format Journal Article
LanguageEnglish
Published England BioMed Central 30.11.2024
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Evidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the progression of this condition. Adipokine chemerin was linked with GDM, yet the roles of chemerin in placental oxidative stress and its underlying effects on GDM in vivo remain elusive. We firstly analyzed the disparities of oxidative stress levels in placenta between GDM and normoglycaemic pregnant women, and then added recombinant active chemerin to the high-glucose treated human trophoblastic cells to investigate effects of chemerin on reactive oxygen species (ROS), total antioxidant capacity (T-AOC) and intake of glucose. Finally, a GDM animal model induced by high-fat diet (HFD) was established and the impacts of chemerin on oxidative stress of placenta and fetal growth of GDM were explored. Analysis of human samples showed that the extent of lipid peroxidation in placenta was significantly elevated in GDM patients compared with their normoglycaemic counterparts. In the high glucose cell model, active chemerin lessened the content of ROS, heightened the index of T-AOC and stimulated glucose uptake in a concentration-dependent manner. Importantly, we successfully constructed a GDM mouse model through HFD. The treatment of chemerin was found to alleviate the high blood glucose levels in these HFD-fed pregnant mice and attenuate the excessive growth of their offspring. Our data also revealed that chemerin might counteract placental oxidative stress in HFD mice by improving the activity of superoxide dismutase. The present study further elucidated the molecular biology of chemerin, which plays a pivotal role in ameliorating oxidative stress and hyperglycemia, resulting in improved fetal overgrowth in GDM.
AbstractList Evidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the progression of this condition. Adipokine chemerin was linked with GDM, yet the roles of chemerin in placental oxidative stress and its underlying effects on GDM in vivo remain elusive. We firstly analyzed the disparities of oxidative stress levels in placenta between GDM and normoglycaemic pregnant women, and then added recombinant active chemerin to the high-glucose treated human trophoblastic cells to investigate effects of chemerin on reactive oxygen species (ROS), total antioxidant capacity (T-AOC) and intake of glucose. Finally, a GDM animal model induced by high-fat diet (HFD) was established and the impacts of chemerin on oxidative stress of placenta and fetal growth of GDM were explored. Analysis of human samples showed that the extent of lipid peroxidation in placenta was significantly elevated in GDM patients compared with their normoglycaemic counterparts. In the high glucose cell model, active chemerin lessened the content of ROS, heightened the index of T-AOC and stimulated glucose uptake in a concentration-dependent manner. Importantly, we successfully constructed a GDM mouse model through HFD. The treatment of chemerin was found to alleviate the high blood glucose levels in these HFD-fed pregnant mice and attenuate the excessive growth of their offspring. Our data also revealed that chemerin might counteract placental oxidative stress in HFD mice by improving the activity of superoxide dismutase. The present study further elucidated the molecular biology of chemerin, which plays a pivotal role in ameliorating oxidative stress and hyperglycemia, resulting in improved fetal overgrowth in GDM.
BackgroundEvidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the progression of this condition. Adipokine chemerin was linked with GDM, yet the roles of chemerin in placental oxidative stress and its underlying effects on GDM in vivo remain elusive.MethodsWe firstly analyzed the disparities of oxidative stress levels in placenta between GDM and normoglycaemic pregnant women, and then added recombinant active chemerin to the high-glucose treated human trophoblastic cells to investigate effects of chemerin on reactive oxygen species (ROS), total antioxidant capacity (T-AOC) and intake of glucose. Finally, a GDM animal model induced by high-fat diet (HFD) was established and the impacts of chemerin on oxidative stress of placenta and fetal growth of GDM were explored.ResultsAnalysis of human samples showed that the extent of lipid peroxidation in placenta was significantly elevated in GDM patients compared with their normoglycaemic counterparts. In the high glucose cell model, active chemerin lessened the content of ROS, heightened the index of T-AOC and stimulated glucose uptake in a concentration-dependent manner. Importantly, we successfully constructed a GDM mouse model through HFD. The treatment of chemerin was found to alleviate the high blood glucose levels in these HFD-fed pregnant mice and attenuate the excessive growth of their offspring. Our data also revealed that chemerin might counteract placental oxidative stress in HFD mice by improving the activity of superoxide dismutase.ConclusionsThe present study further elucidated the molecular biology of chemerin, which plays a pivotal role in ameliorating oxidative stress and hyperglycemia, resulting in improved fetal overgrowth in GDM.
Evidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the progression of this condition. Adipokine chemerin was linked with GDM, yet the roles of chemerin in placental oxidative stress and its underlying effects on GDM in vivo remain elusive.BACKGROUNDEvidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the progression of this condition. Adipokine chemerin was linked with GDM, yet the roles of chemerin in placental oxidative stress and its underlying effects on GDM in vivo remain elusive.We firstly analyzed the disparities of oxidative stress levels in placenta between GDM and normoglycaemic pregnant women, and then added recombinant active chemerin to the high-glucose treated human trophoblastic cells to investigate effects of chemerin on reactive oxygen species (ROS), total antioxidant capacity (T-AOC) and intake of glucose. Finally, a GDM animal model induced by high-fat diet (HFD) was established and the impacts of chemerin on oxidative stress of placenta and fetal growth of GDM were explored.METHODSWe firstly analyzed the disparities of oxidative stress levels in placenta between GDM and normoglycaemic pregnant women, and then added recombinant active chemerin to the high-glucose treated human trophoblastic cells to investigate effects of chemerin on reactive oxygen species (ROS), total antioxidant capacity (T-AOC) and intake of glucose. Finally, a GDM animal model induced by high-fat diet (HFD) was established and the impacts of chemerin on oxidative stress of placenta and fetal growth of GDM were explored.Analysis of human samples showed that the extent of lipid peroxidation in placenta was significantly elevated in GDM patients compared with their normoglycaemic counterparts. In the high glucose cell model, active chemerin lessened the content of ROS, heightened the index of T-AOC and stimulated glucose uptake in a concentration-dependent manner. Importantly, we successfully constructed a GDM mouse model through HFD. The treatment of chemerin was found to alleviate the high blood glucose levels in these HFD-fed pregnant mice and attenuate the excessive growth of their offspring. Our data also revealed that chemerin might counteract placental oxidative stress in HFD mice by improving the activity of superoxide dismutase.RESULTSAnalysis of human samples showed that the extent of lipid peroxidation in placenta was significantly elevated in GDM patients compared with their normoglycaemic counterparts. In the high glucose cell model, active chemerin lessened the content of ROS, heightened the index of T-AOC and stimulated glucose uptake in a concentration-dependent manner. Importantly, we successfully constructed a GDM mouse model through HFD. The treatment of chemerin was found to alleviate the high blood glucose levels in these HFD-fed pregnant mice and attenuate the excessive growth of their offspring. Our data also revealed that chemerin might counteract placental oxidative stress in HFD mice by improving the activity of superoxide dismutase.The present study further elucidated the molecular biology of chemerin, which plays a pivotal role in ameliorating oxidative stress and hyperglycemia, resulting in improved fetal overgrowth in GDM.CONCLUSIONSThe present study further elucidated the molecular biology of chemerin, which plays a pivotal role in ameliorating oxidative stress and hyperglycemia, resulting in improved fetal overgrowth in GDM.
Abstract Background Evidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the progression of this condition. Adipokine chemerin was linked with GDM, yet the roles of chemerin in placental oxidative stress and its underlying effects on GDM in vivo remain elusive. Methods We firstly analyzed the disparities of oxidative stress levels in placenta between GDM and normoglycaemic pregnant women, and then added recombinant active chemerin to the high-glucose treated human trophoblastic cells to investigate effects of chemerin on reactive oxygen species (ROS), total antioxidant capacity (T-AOC) and intake of glucose. Finally, a GDM animal model induced by high-fat diet (HFD) was established and the impacts of chemerin on oxidative stress of placenta and fetal growth of GDM were explored. Results Analysis of human samples showed that the extent of lipid peroxidation in placenta was significantly elevated in GDM patients compared with their normoglycaemic counterparts. In the high glucose cell model, active chemerin lessened the content of ROS, heightened the index of T-AOC and stimulated glucose uptake in a concentration-dependent manner. Importantly, we successfully constructed a GDM mouse model through HFD. The treatment of chemerin was found to alleviate the high blood glucose levels in these HFD-fed pregnant mice and attenuate the excessive growth of their offspring. Our data also revealed that chemerin might counteract placental oxidative stress in HFD mice by improving the activity of superoxide dismutase. Conclusions The present study further elucidated the molecular biology of chemerin, which plays a pivotal role in ameliorating oxidative stress and hyperglycemia, resulting in improved fetal overgrowth in GDM. Graphical abstract
ArticleNumber 239
Author Wang, Zizhuo
Wei, Lijie
Fang, Chenyun
Du, Yuanyuan
Zhang, Huiting
Ding, Wencheng
Li, Weikun
Jiang, Yi
Zhang, Liangnan
Zhou, Xuan
He, Zhenzhen
He, Mengzhou
Feng, Ling
Su, Rui
Zhu, Shenglan
Tan, Weidong
Wang, Shaoshuai
Yu, Jun
Author_xml – sequence: 1
  givenname: Xuan
  orcidid: 0000-0002-1345-1498
  surname: Zhou
  fullname: Zhou, Xuan
– sequence: 2
  givenname: Yi
  surname: Jiang
  fullname: Jiang, Yi
– sequence: 3
  givenname: Zizhuo
  surname: Wang
  fullname: Wang, Zizhuo
– sequence: 4
  givenname: Lijie
  surname: Wei
  fullname: Wei, Lijie
– sequence: 5
  givenname: Huiting
  surname: Zhang
  fullname: Zhang, Huiting
– sequence: 6
  givenname: Chenyun
  surname: Fang
  fullname: Fang, Chenyun
– sequence: 7
  givenname: Shenglan
  surname: Zhu
  fullname: Zhu, Shenglan
– sequence: 8
  givenname: Yuanyuan
  surname: Du
  fullname: Du, Yuanyuan
– sequence: 9
  givenname: Rui
  surname: Su
  fullname: Su, Rui
– sequence: 10
  givenname: Weikun
  surname: Li
  fullname: Li, Weikun
– sequence: 11
  givenname: Zhenzhen
  surname: He
  fullname: He, Zhenzhen
– sequence: 12
  givenname: Liangnan
  surname: Zhang
  fullname: Zhang, Liangnan
– sequence: 13
  givenname: Weidong
  surname: Tan
  fullname: Tan, Weidong
– sequence: 14
  givenname: Mengzhou
  surname: He
  fullname: He, Mengzhou
– sequence: 15
  givenname: Jun
  surname: Yu
  fullname: Yu, Jun
– sequence: 16
  givenname: Shaoshuai
  surname: Wang
  fullname: Wang, Shaoshuai
– sequence: 17
  givenname: Wencheng
  surname: Ding
  fullname: Ding, Wencheng
– sequence: 18
  givenname: Ling
  orcidid: 0000-0001-8833-5574
  surname: Feng
  fullname: Feng, Ling
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39616329$$D View this record in MEDLINE/PubMed
BookMark eNpdksuO1DAQRSM0iHnAD7BAltiwCfiROPYKoRaPkUZiA2urYlc6bqXjxnZ6mK_gl3F3D6MZVi65jq_Kt-5ldTaHGavqNaPvGVPyQ2KUclpT3tS0lF3Nn1UXrOWqFrJVZ4_q8-oypU2hWdu0L6pzoSWTguuL6s9qxC1GPxOYJtx7yJhIHpHsJrA4Z5hI-O0dZL9HknLElAjMjvjtLoZ9YQc8MnuM6xhu80jCQNaYcnkR5tJxHno8iG5xmnxeSuEtEj-7xaIj_R0Z_XokA-SCYn5ZPR9gSvjq_ryqfn75_GP1rb75_vV69emmtm2jc-2EBgadaLloregBm_I56bhtBDrBB8b7VnChsFxRaengoHO6B9W1WupWiKvq-qTrAmzMLvotxDsTwJvjRYhrAzF7O6EB6HqqlRoEg6ZvbFFRqtO6daiVVU3R-njS2i39Ft3BtgjTE9GnndmPZh32hjFJO8VlUXh3rxDDr6W4Z7Y-2WIYzBiWZARrqNKiLK-gb_9DN2GJxekDJZVWQsquUG8ej_Qwy7_FF4CfABtDShGHB4RRc0iXOaXLlHSZY7oMF38Bpg3EhA
Cites_doi 10.1016/j.mce.2021.111369
10.1113/JP280593
10.3390/ijms222111578
10.3390/antiox12030658
10.1631/jzus.B2000432
10.2337/dc24-S002
10.3390/antiox12101812
10.1016/j.phrs.2021.105987
10.3390/biomedicines10082018
10.4093/dmj.2021.0216
10.1016/j.redox.2022.102554
10.3390/ijms21103570
10.1016/j.apsb.2021.05.011
10.1038/s41401-023-01216-1
10.1096/fj.202201611R
10.1038/s42003-020-0986-1
10.1096/fj.202000326RR
10.1038/s41574-022-00734-y
10.1038/s41467-020-20665-4
10.3390/biomedicines12040924
10.1016/j.bbadis.2020.165967
10.1186/s10020-023-00669-8
10.1097/FM9.0000000000000044
10.7150/ijbs.84890
10.1530/JOE-18-0174
10.3390/nu15132878
10.1007/s00018-024-05192-5
10.1186/s10020-023-00707-5
10.1146/annurev-nutr-082018-124228
10.3390/antiox10030405
10.1016/j.redox.2021.101964
10.1016/j.peptides.2020.170422
10.1186/s10020-023-00615-8
10.1136/bmj.m1361
10.3390/ijms21249408
10.1111/1440-1681.13172
10.1136/bmj-2021-067946
10.2337/dbi18-0052
ContentType Journal Article
Copyright 2024. The Author(s).
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s10020-024-01007-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: ProQuest Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1528-3658
EndPage 16
ExternalDocumentID oai_doaj_org_article_aa7b0988f31a4b4cba8887995de98c84
PMC11607826
39616329
10_1186_s10020_024_01007_2
Genre Journal Article
GeographicLocations United States--US
China
Germany
GeographicLocations_xml – name: China
– name: United States--US
– name: Germany
GrantInformation_xml – fundername: National Key Research and Development Program of China
  grantid: 2022YFC2704702
– fundername: National Key Research and Development Program of China
  grantid: 2021YFC2701502
GroupedDBID ---
-ET
0R~
123
29M
2WC
36B
5RE
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFO
ACMJI
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
IAO
IH2
IHR
ISR
ITC
KQ8
LGEZI
LOTEE
NADUK
NXXTH
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
RBZ
RNS
ROL
RPM
RSV
SDH
SJN
SOJ
SV3
TR2
UKHRP
WOQ
ACRMQ
C24
CGR
CUY
CVF
ECM
EIF
M~E
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c549t-d39a1a735235c3bae40026d2c43ed32f12b53238ed2c06c0fda7d9ba875969533
IEDL.DBID 7X7
ISSN 1528-3658
1076-1551
IngestDate Wed Aug 27 01:23:41 EDT 2025
Thu Aug 21 18:36:27 EDT 2025
Thu Jul 10 17:07:49 EDT 2025
Mon Jun 30 12:41:50 EDT 2025
Thu Jan 02 22:24:24 EST 2025
Tue Jul 01 01:25:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Chemerin
Fetal growth
Gestational diabetes mellitus
Animal model
Oxidative stress
Placenta
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c549t-d39a1a735235c3bae40026d2c43ed32f12b53238ed2c06c0fda7d9ba875969533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8833-5574
0000-0002-1345-1498
OpenAccessLink https://www.proquest.com/docview/3168983667?pq-origsite=%requestingapplication%
PMID 39616329
PQID 3168983667
PQPubID 5066171
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_aa7b0988f31a4b4cba8887995de98c84
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11607826
proquest_miscellaneous_3140893545
proquest_journals_3168983667
pubmed_primary_39616329
crossref_primary_10_1186_s10020_024_01007_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-11-30
PublicationDateYYYYMMDD 2024-11-30
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-30
  day: 30
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
– name: London
PublicationTitle Molecular medicine (Cambridge, Mass.)
PublicationTitleAlternate Mol Med
PublicationYear 2024
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References JF Hebert (1007_CR17) 2021; 1867
J Gong (1007_CR15) 2024; 20
E Vounzoulaki (1007_CR31) 2020; 369
JJ Fisher (1007_CR13) 2020; 47
M Ruszała (1007_CR26) 2021; 22
J Fang (1007_CR11) 2023; 29
JJ Fisher (1007_CR14) 2021; 599
XQ Hu (1007_CR20) 2021; 10
X Zhou (1007_CR43) 2020; 2
P Gutaj (1007_CR16) 2020; 21
J Bai (1007_CR5) 2019; 68
X Tang (1007_CR29) 2023; 47
G Helfer (1007_CR19) 2018; 238
KA Cojocaru (1007_CR7) 2023; 12
X An (1007_CR2) 2020; 135
M Yang (1007_CR32) 2024; 45
Y Yin (1007_CR35) 2022; 175
WS Blaner (1007_CR6) 2021; 41
L Jiang (1007_CR21) 2022; 18
J Zaugg (1007_CR36) 2024; 81
L Zhao (1007_CR40) 2024; 12
K Zorena (1007_CR45) 2020; 21
J Bai (1007_CR4) 2020; 3
L Li (1007_CR23) 2023; 29
X Zhou (1007_CR44) 2023; 37
L Tan (1007_CR28) 2023; 15
1007_CR1
C Lennicke (1007_CR22) 2021; 42
AM Valent (1007_CR30) 2021; 35
H Zhou (1007_CR41) 2021; 12
R Saucedo (1007_CR27) 2023; 12
Y Deng (1007_CR9) 2023; 29
W Ye (1007_CR33) 2022; 377
X Zhou (1007_CR42) 2020; 21
P Fang (1007_CR12) 2021; 535
L Zhao (1007_CR39) 2022; 10
PK Oduro (1007_CR24) 2022; 12
J Zhang (1007_CR37) 2022; 58
References_xml – volume: 535
  start-page: 111369
  year: 2021
  ident: 1007_CR12
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2021.111369
– volume: 599
  start-page: 1291
  issue: 4
  year: 2021
  ident: 1007_CR14
  publication-title: J Physiol
  doi: 10.1113/JP280593
– volume: 22
  start-page: 11578
  issue: 21
  year: 2021
  ident: 1007_CR26
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms222111578
– volume: 12
  start-page: 658
  issue: 3
  year: 2023
  ident: 1007_CR7
  publication-title: Antioxid (Basel)
  doi: 10.3390/antiox12030658
– volume: 21
  start-page: 990
  issue: 12
  year: 2020
  ident: 1007_CR42
  publication-title: J Zhejiang Univ Sci B
  doi: 10.1631/jzus.B2000432
– ident: 1007_CR1
  doi: 10.2337/dc24-S002
– volume: 12
  start-page: 1812
  issue: 10
  year: 2023
  ident: 1007_CR27
  publication-title: Antioxid (Basel)
  doi: 10.3390/antiox12101812
– volume: 175
  start-page: 105987
  year: 2022
  ident: 1007_CR35
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2021.105987
– volume: 10
  start-page: 2018
  issue: 8
  year: 2022
  ident: 1007_CR39
  publication-title: Biomedicines
  doi: 10.3390/biomedicines10082018
– volume: 47
  start-page: 267
  issue: 2
  year: 2023
  ident: 1007_CR29
  publication-title: Diabetes Metab J
  doi: 10.4093/dmj.2021.0216
– volume: 58
  start-page: 102554
  year: 2022
  ident: 1007_CR37
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2022.102554
– volume: 21
  start-page: 3570
  issue: 10
  year: 2020
  ident: 1007_CR45
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21103570
– volume: 12
  start-page: 50
  issue: 1
  year: 2022
  ident: 1007_CR24
  publication-title: Acta Pharm Sin B
  doi: 10.1016/j.apsb.2021.05.011
– volume: 45
  start-page: 777
  issue: 4
  year: 2024
  ident: 1007_CR32
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/s41401-023-01216-1
– volume: 37
  start-page: e22806
  issue: 3
  year: 2023
  ident: 1007_CR44
  publication-title: FASEB J
  doi: 10.1096/fj.202201611R
– volume: 3
  start-page: 257
  issue: 1
  year: 2020
  ident: 1007_CR4
  publication-title: Commun Biol
  doi: 10.1038/s42003-020-0986-1
– volume: 35
  start-page: e21423
  issue: 3
  year: 2021
  ident: 1007_CR30
  publication-title: FASEB J
  doi: 10.1096/fj.202000326RR
– volume: 18
  start-page: 760
  issue: 12
  year: 2022
  ident: 1007_CR21
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/s41574-022-00734-y
– volume: 12
  start-page: 326
  issue: 1
  year: 2021
  ident: 1007_CR41
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-20665-4
– volume: 12
  start-page: 924
  issue: 4
  year: 2024
  ident: 1007_CR40
  publication-title: Biomedicines
  doi: 10.3390/biomedicines12040924
– volume: 1867
  start-page: 165967
  issue: 1
  year: 2021
  ident: 1007_CR17
  publication-title: Biochim Biophys Acta Mol Basis Dis
  doi: 10.1016/j.bbadis.2020.165967
– volume: 29
  start-page: 82
  issue: 1
  year: 2023
  ident: 1007_CR23
  publication-title: Mol Med
  doi: 10.1186/s10020-023-00669-8
– volume: 2
  start-page: 131
  issue: 3
  year: 2020
  ident: 1007_CR43
  publication-title: Maternal-Fetal Med
  doi: 10.1097/FM9.0000000000000044
– volume: 20
  start-page: 152
  issue: 1
  year: 2024
  ident: 1007_CR15
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.84890
– volume: 238
  start-page: R79
  issue: 2
  year: 2018
  ident: 1007_CR19
  publication-title: J Endocrinol
  doi: 10.1530/JOE-18-0174
– volume: 15
  start-page: 2878
  issue: 13
  year: 2023
  ident: 1007_CR28
  publication-title: Nutrients
  doi: 10.3390/nu15132878
– volume: 81
  start-page: 151
  issue: 1
  year: 2024
  ident: 1007_CR36
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-024-05192-5
– volume: 29
  start-page: 115
  issue: 1
  year: 2023
  ident: 1007_CR9
  publication-title: Mol Med
  doi: 10.1186/s10020-023-00707-5
– volume: 41
  start-page: 105
  year: 2021
  ident: 1007_CR6
  publication-title: Annu Rev Nutr
  doi: 10.1146/annurev-nutr-082018-124228
– volume: 10
  start-page: 405
  issue: 3
  year: 2021
  ident: 1007_CR20
  publication-title: Antioxid (Basel)
  doi: 10.3390/antiox10030405
– volume: 42
  start-page: 101964
  year: 2021
  ident: 1007_CR22
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2021.101964
– volume: 135
  start-page: 170422
  year: 2020
  ident: 1007_CR2
  publication-title: Peptides
  doi: 10.1016/j.peptides.2020.170422
– volume: 29
  start-page: 23
  issue: 1
  year: 2023
  ident: 1007_CR11
  publication-title: Mol Med
  doi: 10.1186/s10020-023-00615-8
– volume: 369
  start-page: m1361
  year: 2020
  ident: 1007_CR31
  publication-title: BMJ
  doi: 10.1136/bmj.m1361
– volume: 21
  start-page: 9408
  issue: 24
  year: 2020
  ident: 1007_CR16
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21249408
– volume: 47
  start-page: 176
  issue: 1
  year: 2020
  ident: 1007_CR13
  publication-title: Clin Exp Pharmacol Physiol
  doi: 10.1111/1440-1681.13172
– volume: 377
  start-page: e067946
  year: 2022
  ident: 1007_CR33
  publication-title: BMJ
  doi: 10.1136/bmj-2021-067946
– volume: 68
  start-page: 1099
  issue: 6
  year: 2019
  ident: 1007_CR5
  publication-title: Diabetes
  doi: 10.2337/dbi18-0052
SSID ssj0021545
Score 2.4364462
Snippet Evidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable to the...
BackgroundEvidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is indispensable...
Abstract Background Evidence has shown that oxidative stress induced by high glucose microenvironment in placenta of gestational diabetes mellitus (GDM) is...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 239
SubjectTerms Adult
Animal model
Animals
Antioxidants
Biotechnology
Cell culture
Chemerin
Chemokines - metabolism
Diabetes, Gestational - metabolism
Diet
Diet, High-Fat - adverse effects
Disease Models, Animal
Female
Females
Fetal growth
Gestational diabetes
Gestational diabetes mellitus
Glucose
Humans
Insulin resistance
Intercellular Signaling Peptides and Proteins
Kinases
Laboratory animals
Mice
Oxidative Stress
Placenta
Placenta - metabolism
Pregnancy
Proteins
Reactive oxygen species
Reactive Oxygen Species - metabolism
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Ni9RAEC1kYcGL6K4f0XUpwZsEk3TSnT6q7DAI68mBuTX9FXcOZsTNiPsr9i9b1UmGHRH2IrmEpA6dVHXqvU7XK4C3tlKFlULkImpBBEXp3FHiyhWlK1fIrlCKC4Uvv8jlqv68btZ3Wn3xnrBRHnh8ce-tVa7QbduJ0tau9s4SZ2MVsxB169ukBEo5byZTE9ViYDCXyLSSC-WYJlE-IurMi3PVQRpKav3_gph_75S8k3oWj-HRhBnxwzjWJ_Ag9idwPHaRvDmFWy765yo-5L4ovzaMHpFwHab9VlztiNvfm5AUvnGsDUHbB9yk9QSy7WKyoaD-RqR8uMJth_zbaVonxHl9Fr-zeuewoxP6vCCxeYqLgO4GWfQYOzuQaRyewmpx8fXTMp_6LOSe2OGQB6FtaRVBMdF44WysmZmFytciBlF1ZeUaQak90qVC-qILVgVNjlCNlrw99Rkc9ds-vgB0Sghfxo6OkjKdt5ac00Td1FYHX_gM3s2v3fwY5TRMoiGtNKOTDDnJJCeZKoOP7Jm9JUthpwsUIGYKEHNfgGRwNvvVTPPz2nC7Lt0KKVUGb_a3aWbx7xLbx-2ObeqC0BxFUgbPxzDYj0RoSUC20hm0BwFyMNTDO_3mKql3lyzpR6Tu5f94uFfwsOKoTlqUZ3A0_NzF14SSBneeJsQf63sSIg
  priority: 102
  providerName: Directory of Open Access Journals
Title Chemerin alleviates the placental oxidative stress and improves fetal overgrowth of gestational diabetes mellitus mice induced by high fat diet
URI https://www.ncbi.nlm.nih.gov/pubmed/39616329
https://www.proquest.com/docview/3168983667
https://www.proquest.com/docview/3140893545
https://pubmed.ncbi.nlm.nih.gov/PMC11607826
https://doaj.org/article/aa7b0988f31a4b4cba8887995de98c84
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9RAEB60RfBF_G20Hiv4JsFkN9nNPomV1iJYRCzc27K_0t5Dk9rmxP4V_svObJKrJyIHx5Hsw3Izu_N9szvfALy2XBVWCpGLqAUSFKVzh4ErVxiuXCHbQikqFP58LI9Oqk_Lejkl3K6ma5Xznpg26tB7ypG_pQZLuhFSqncX33PqGkWnq1MLjduwS9Jl5NVqeUO4CB6Mdw5lTtBgLpppJJXOEXHCCIVkmtJ1fCswJf3-f4HOv-9O_hGMDu_DvQlFsvej2R_Ardg9hDtjX8nrR_CLZACoro9Rp5QfK8KTDJEeSzewqP6R9T9XIWl-s7FahNkusFXKMODYNqYx6OanSNOHM9a3jA6ipswhmzO27Jz0PIc1_sANhyG_R08JzF0zkkFmrR1waBwew8nhwbcPR_nUeSH3yBeHPAhtS6sQnInaC2djRVwtcF-JGARvS-5qgcE-4qNC-qINVgXtLJIfLenC6hPY6fouPgPmlBC-jC1-Sox93lqOqC7qurI6-MJn8Gb-283FKLBhEjFppBmNZNBIJhnJ8Az2yTKbkSSOnR70l6dmWmvGWuUK3TStKG3lKo_zwq1U6zpE3fimymBvtquZVuyVufGvDF5tXuNaowMU28V-TWOqAvEdelUGT0c32MxEaInQlusMmi0H2Zrq9ptudZb0vEsS-UOa9_z_83oBdzn5a9Kd3IOd4XIdXyIiGtwiuf0CdvcPjr98XaS8An5_XJa_AZ4YDso
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxJtAASPBCUUkdtaODwjxqrb0cWqlvRnHdto9kJRtlrK_gn_Cb2TG2WxZhLhVe1klo5W18_pmPA-AF5arzEohUhG0wABF6bRCx5UqdFdVJutMKWoU3j-Q46Pi82Q02YBfQy8MlVUONjEaat86ypG_pgVLuhRSqren31LaGkW3q8MKjV4sdsPiHEO2szc7H5G_Lznf_nT4YZwutwqkDmOhLvVC29wqBB5i5ERlQ0FxiOeuEMELXue8Ggl0ZAEfZdJltbfK68oisNeSijHxd6_AVXS8GQV7anIR4BEc6WscZUpQZGjSKSW16lGghh4Rg3dKD_I1Rxj3BfwL5P5dq_mH89u-BTeXqJW968XsNmyE5g5c6_dYLu7CTxo7QH2EjDazfJ8SfmWILFms-KJ-S9b-mPo4Y5z13SnMNp5NY0YDaesQaVCtjmfteXfC2prRxdcyU8mGDDH7SvNDuzl-QQPHpo1HyfSsWjAau8xq2yFp6O7B0aXw5D5sNm0THgKrlBAuDzV-cvS1zlqOKDLoUWG1d5lL4NXwt5vTfqCHiYFQKU3PJINMMpFJhifwnjizoqRh3PFBOzs2S9021qoq02VZi9wWVeHwXGi6tR75oEtXFglsDXw1SwtxZi7kOYHnq9eo23RhY5vQzommyBBPolQl8KAXg9VJhJYIpblOoFwTkLWjrr9ppidxfnhOQwUxrHz0_3M9g-vjw_09s7dzsPsYbnCS3Tjzcgs2u9k8PEE01lVPowow-HLZOvcbeAVHbQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEG8CBYwEJxQ1sbNOfECI0lYthVWFqNSbcWyn3QNJ2WYp-yv4P_w6ZpxkYRHiVu1llYxW1s7rm_E8AJ4bnidGChELrwQGKLmKS3RccY7uqkxkleQ5NQp_mMi9o-zd8fh4DX4OvTBUVjnYxGCoXWMpR75JC5ZUIaTMN6u-LOJwe_f12deYNkjRTeuwTqMTkQO_uMDw7fzV_jby-gXnuzuf3u7F_YaB2GJc1MZOKJOaHEGIGFtRGp9RTOK4zYR3glcpL8cCnZrHR4m0SeVM7lRpEOQrSYWZ-LtXYD2nqGgE61s7k8OPy3CPwElX8ShjAiZDy04hqXGPwjb0jxjKU7KQr7jFsD3gX5D378rNP1zh7k240WNY9qYTuluw5uvbcLXbarm4Az9oCAF1FTLa0_JtSmiWIc5kof6Lui9Z833qwsRx1vWqMFM7Ng35DaStfKBBJTuZNRftKWsqRtdgfd6SDfli9oWmibZz_ILmjk1rh3LqWLlgNISZVaZFUt_ehaNL4co9GNVN7R8AK3MhbOor_KToea0xHDGlV-PMKGcTG8HL4W_XZ914Dx3CokLqjkkamaQDkzSPYIs4s6Sk0dzhQTM70b2ma2PyMlFFUYnUZGVm8VxoyJUaO68KW2QRbAx81b29ONe_pTuCZ8vXqOl0fWNq38yJJksQXaJURXC_E4PlSYSSCKy5iqBYEZCVo66-qaenYZp4SiMGMch8-P9zPYVrqG_6_f7k4BFc5yS6YQDmBoza2dw_RmjWlk96HWDw-bLV7hc3Ak0I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemerin+alleviates+the+placental+oxidative+stress+and+improves+fetal+overgrowth+of+gestational+diabetes+mellitus+mice+induced+by+high+fat+diet&rft.jtitle=Molecular+medicine+%28Cambridge%2C+Mass.%29&rft.au=Zhou%2C+Xuan&rft.au=Jiang%2C+Yi&rft.au=Wang%2C+Zizhuo&rft.au=Wei%2C+Lijie&rft.date=2024-11-30&rft.issn=1528-3658&rft.eissn=1528-3658&rft.volume=30&rft.issue=1&rft_id=info:doi/10.1186%2Fs10020-024-01007-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s10020_024_01007_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-3658&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-3658&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-3658&client=summon